Written in partnership with All About Vision

An oddity of American healthcare financing is that, as a general matter, healthcare insurance companies are quite specialized, though the way the coverage lines are drawn isn’t all that intuitive. The insurance card in your wallet is for medical expenses broadly, but prescription drugs are handled by a pharmacy benefit manager (PBM), which may or may not be integrated with your medical insurance. Teeth and gums are a separate company, often not integrated in any meaningful sense, and when it comes to your eyes, whether they’re covered by vision or medical insurance is a case of “it depends.”

This confusion obscures the growing importance of an estimated $69.5b market that cuts across payer and patient types. Eye care also has its own Medicare Advantage (MA) Star Ratings measure, a steady flow of private market financing activity, and an increasingly important clinical and diagnostic role, with the American Optometric Association (AOA) noting that doctors of optometry (ODs) can identify early warning signs of more than 270 systemic and chronic diseases through an eye exam.

In coordination with All About Vision and The Harris Poll, we have paired our own research on the eye care segment with their survey data.

People know eye exams are important, but there’s a steep drop-off when it comes to actually getting them

85% of adults say a comprehensive eye exam is at least as important as a routine physical, but only 48% get one every year. By way of comparison, 74% say they get a routine physical and 66% get dental cleanings.

Nearly three in four adults report a barrier, and the barriers differ by age

Cost or lack of coverage is a significant barrier at 37%, but adults under 35 are also far more likely than older adults to cite time and perceived need: 32% say they’re too busy or forget, and 24% say an exam isn’t necessary without symptoms.

Part of the cost problem may be driven by coordination-of-benefits confusion

An annual to biannual eye exam and glasses prescription analysis can run through either a vision plan or medical insurance depending on insurance coverage and needs of the patient. A visit for a medical reason, such as diabetes, glaucoma, or dry eyes, is a medical expense, and what gets billed often depends on how the practice codes the visit. It’s reminiscent of coordination-of-benefits challenges for certain types of injectable or infusible prescription drugs or oral surgery. 89% of adults say knowing what a comprehensive eye exam includes would make them more likely to get one, which suggests clearer communication could help bridge the gap.

Seniors are the most engaged eye care consumers, but Original Medicare doesn’t cover eyewear, and MA eyewear allowances are shrinking

An annual comprehensive eye exam is recommended for those 65 and older, and 64% of seniors get one — the highest rate of any age group, likely due to a combination of need and coverage, though it’s worth mentioning that while it’s a standard MA supplemental benefit, vision benefits aren’t part of Original Medicare.

HTN analysis of Centers for Medicare & Medicaid Services (CMS) plan benefit files shows vision benefits are included in about 98% of plans from 2025 through 2027, though eyewear allowances are trending down. Among general-enrollment plans with a dollar cap, the average eyewear allowance is $186 in 2027, down 23% from $242 in 2025, and the share of general-enrollment plans offering $100 or less has nearly doubled, from 15% to 29%.

The eye exam’s value for whole-body health is underappreciated, though it’s on payers’ radar

Most respondents understand that a comprehensive eye exam can detect eye conditions, but only 29% know an exam could show signs of cardiovascular conditions, and 24% know it might show signs of neurological conditions.

MA Star Ratings include an eye exam measure for members with diabetes, so the diagnostic value of eye exams is already top of mind for payers. On Humana’s Q3 call, CEO Jim Rechtin said 73,000 members with diabetes received an overdue eye exam, which identified 17,000 previously undetected diagnoses of diabetes-related eye disease.

For kids, parents see myopia’s risks but don’t know what can be done

All About Vision’s “Myopia Awareness Gap” survey, conducted by The Harris Poll, found that 48% of parents believe nothing can be done to reduce a child’s risk of nearsightedness despite relatively straightforward interventions like holding screens at a proper distance, spending at least 2 hours outside, and using myopia-control treatment options.

Investors are betting on the retina

Venture capital investment in ophthalmology more than doubled to just under $2b in 2025 from $934m in 2024, as retina-focused investments were the lion's share, accounting for $1.4b per a Market Scope report. 

This bolsters our friends at All About Vision’s description of this moment as the “golden age of the retina.”

Eye care is benefiting from AI tailwinds as well. Autonomous AI that screens retinal images for diabetic eye disease is already FDA-cleared, and oculomics — which looks for signs of heart, kidney, and brain disease in retinal scans — is advancing rapidly.

What HTN is keeping an eye on:

  • Consumers: How does the proliferation of FSAs/HSAs/HRAs as well as combination wearable and vision technology change behavior around eye exams and eye care utilization going forward?

  • Commercial and Medicare Advantage insurance: What happens with MA eyewear allowances in next year’s bids, and will eye exams start to play a larger role in detection and monitoring of non-eye diseases in commercial populations?

  • Startups and tech: FDA clearance of new retina diagnostics and where venture investment goes next

All About Vision covers these developments for consumers and eye care professionals. Read the full results from the comprehensive eye exam survey and the Myopia Awareness Gap report. 

To stay on top of the latest news and more, feel free to subscribe at allaboutvision.com/subscribe.

Disclaimer: This article is based on information and original survey data provided by All About Vision and The Harris Poll. It does not represent the opinions or conclusions of All About Vision.